Julien Cherfils-Vicini
9PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.Imène Krossa, Céline Pisibon, Yann Cheli
|Dec 28, 2024
A ganglioside-based immune checkpoint enables senescent cells to evade immunosurveillance during aging.Charlène Iltis, Iryna Moskalevska, Antoine Debiesse
|Apr 21, 2021
Neutrophils: mediating TelOxidation and senescence.Maria Sol Jacome Burbano, Julien Cherfils-Vicini, Eric Gilson
|Apr 02, 2021
Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma.Marius Ilié, Elisabeth Lantéri, Emmanuel Chamorey
|Jan 29, 2021
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.Laetitia Douguet, Serena Janho Dit Hreich, Jonathan Benzaquen
Pageof 2
Frequent Collaborators
5 joint publications
Eric Gilson
1 joint publications
Pasquale Zizza
1 joint publications
Annamaria Biroccio
1 joint publications
Serena Janho Dit Hreich
1 joint publications
Christophe Duranton
1 joint publications
Cecile Delarasse
1 joint publications
Sahil Adriouch
1 joint publications
Alina Ghinet
1 joint publications
Valérie Vouret-Craviari
1 joint publications
Elisabeth Lantéri